Serum Institute's 2nd Covid vaccine likely to be launched in September

Gallery

MORE...

Sports

U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals

The 18-year-old, Chirag Chikkara clinched a gold medal in the men’s freestyle 57kg categ

FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup

Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow

FIFA : Over 100 female footballers urge FIFA to reconsider partnership with Saudi oil giant

Ecuador ready to make history against Uruguay: Beccacece

Divanshi wins second gold as India sweep women's 25m standard pistol at Lima Junior Worlds

MORE...

Serum Institute's 2nd Covid vaccine likely to be launched in September

Last Updated : 27 Mar 2021 03:18:58 PM IST

Serum Institute CEO Adar Poonawalla

Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax by September this year, CEO Adar Poonawalla announced on Saturday.

"Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India," said Adar Poonawalla.

He further said that it has been tested against African and UK variants of Covid-19 and has an overall efficacy of 89 per cent. "Hope to launch by September 2021!" the CEO of world's biggest Covid-19 vaccine maker said.

Covovax is the protein-based Covid-19 vaccine developed by Novavax, headquartered in the US.

In August 2020, the two companies announced an agreement under which Novavax had given SII the licence to manufacture and supply the vaccine in low- and middle-income countries.